🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Status
Unknown
Location
Garden State Cancer Center
Start Date
2000-08
Trial ID
NCT00006458
Treatments Being Tested
The aim of the study is to test \[90\]Y-ibritumomab tiuxetan, a radioactive...
Status
Completed
Location
Multiple Locations
Start Date
2001-08
Trial ID
NCT00185393
Treatments Being Tested
Primary Objective: To demonstrate sufficiency of the vaccine seroresponse ...
Status
Completed
Location
Investigational Site Number 8400026
Start Date
2019-10-04
Trial ID
NCT04142242
The purpose of this study is to identify maximum tolerated dose (MTD), that...
Status
Completed
Location
Northwestern University
Start Date
2016-07
Trial ID
NCT02837029
Treatments Being Tested
This phase I trial studies the side effects and best dose of yttrium Y 90 a...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2012-01-09
Trial ID
NCT01503242
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Unknown
Location
Medizinische Klinik, Klinikum Augsburg
Start Date
2005-06
Trial ID
NCT00397800
Treatments Being Tested
The primary objective was to evaluate the persistence of bactericidal antib...
Status
Completed
Location
Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615
Start Date
2010-07
Trial ID
NCT01148017
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and d...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2000-04
Trial ID
NCT00006040
Phase I trial to study the effectiveness of radiolabeled monoclonal antibod...
Status
Completed
Location
University of Alabama Comprehensive Cancer Center
Start Date
1996-03
Trial ID
NCT00002734